1 Min Read
June 18 (Reuters) - IDORSIA LTD:
* IS INITIATING REACT - PHASE 3 REGISTRATION STUDY WITH CLAZOSENTAN Source text for Eikon: Further company coverage: (Gdynia Newsroom)
All quotes delayed a minimum of 15 minutes. See here for a complete list of exchanges and delays.
© 2018 Reuters. All Rights Reserved.